Structure-based design of vaccines, particularly the iterative optimization used so successfully in the structure-based design of drugs, has been a long-sought goal. We previously developed a ...

G protein-coupled receptors (GPCRs) are targets for about 35 percent of approved drugs, but a large proportion of GPCRs remain structurally uncharacterized. Producing stable and functional receptor ...